Online PCT Training for Clinicians
临床医生在线 PCT 培训
基本信息
- 批准号:7912669
- 负责人:
- 金额:$ 70.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-04-01 至 2012-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAdvisory CommitteesAgoraphobiaAnxietyBehavior TherapyChronicClientClinicalClinical Trials DesignCommunitiesCompetenceConsultationsControlled StudyDataDevelopmentDiagnosisDoctor of PhilosophyEnsureEvaluationEvidence based treatmentFeedbackFilmFocus GroupsFundingGoalsGrantHourHybridsIndividualInterviewJob ApplicationKnowledgeLearningLightLocationManualsMissionOutcomePanicPanic AttackPanic DisorderPatientsPerformancePersonsPhasePilot ProjectsPopulationPrevalenceProcessRandomized Controlled TrialsReactionReportingResearchResearch DesignSamplingSelf EfficacySenior ScientistTestingTextTrainingWorkbaseclinical applicationclinical practicecomputer generatedcostdesignfollow-upimprovedinnovationinterestmeetingspanic control treatmentpanic disorder with agoraphobiaprogramsprototypepublic health relevancesatisfactionsuccesstoolusability
项目摘要
DESCRIPTION (provided by applicant): Panic attacks (PA) impact about 23% of adults in community samples. Panic disorder with or without agoraphobia (PDA) tends to be a chronic condition with a lifetime prevalence of 4.7%. When untreated, panic disorder (PD) often leads to debilitating problems, with severe financial and interpersonal costs. Panic Control Treatment (PCT) is an efficacious treatment for PD. The overarching goal of this project is to facilitate the dissemination of PCT (aka MAP; Mastery of Your Anxiety and Panic) to clinicians who treat PD by creating the Online PCT Training for Clinicians (PCT OLT). In Phase I, we produced an innovative OLT prototype comprised of 143 screens using an iterative process of development with feedback from target end-users and PCT experts. A randomized controlled trial (RCT; N=31) was then conducted comparing the PCT OLT to a control OLT. PCT OLT subjects significantly outperformed controls on all outcome variables, including knowledge, recall, and self-efficacy. Results were maintained at the one week follow up. The proposed Phase II project extends this work by expanding the OLT and its evaluation in Phase II. Specifically, we will include all remaining content from the PCT manuals and add additional clinical scenarios and performance-based interactivities. We will test the program's efficacy in a RCT (N=180) using an additive research design of three training approaches: text (n=60), text + PCT OLT (PCT OLT; n=60), vs. text + PCT OLT + expert weekly consultation (Hybrid; n= 60). Outcome variables will again include PCT knowledge, as well as self-efficacy in treating PDA clients with PCT. We will expand the assessments to include a computer- generated clinical application test of competence and fidelity to PCT and course completion. Subjects will be assessed pre- and post-training, then again at 30-day and 60-day post-training follow-ups.
PUBLIC HEALTH RELEVANCE: Although empirically-based treatments do exist for people diagnosed with panic disorder (PD), only a relatively small percentage of this population will receive such treatments. Panic Control Treatment (aka Mastery of Anxiety and Panic; MAP) is an efficacious treatment for PD. The intent of this project is to develop a uniquely comprehensive and interactive online training in MAP, to aid in the dissemination of this evidence based treatment, in order to improve clinical outcomes for patients suffering from PD.
描述(由申请人提供):社区样本中大约 23% 的成年人受到惊恐发作 (PA) 的影响。伴有或不伴有广场恐惧症 (PDA) 的恐慌症往往是一种慢性疾病,终生患病率为 4.7%。如果不及时治疗,恐慌症 (PD) 往往会导致衰弱问题,并带来严重的经济和人际关系成本。恐慌控制治疗 (PCT) 是治疗 PD 的有效方法。该项目的总体目标是通过创建在线 PCT 临床医生培训 (PCT OLT),促进向治疗 PD 的临床医生传播 PCT(又名 MAP;掌握焦虑和恐慌)。在第一阶段,我们利用迭代开发过程以及目标最终用户和 PCT 专家的反馈,生产了一个由 143 个屏幕组成的创新 OLT 原型。随后进行了一项随机对照试验(RCT;N=31),将 PCT OLT 与对照 OLT 进行比较。 PCT OLT 受试者在所有结果变量(包括知识、回忆和自我效能)方面均显着优于对照组。结果维持在一周的随访中。拟议的第二阶段项目通过扩展第二阶段的 OLT 及其评估来扩展这项工作。具体来说,我们将包含 PCT 手册中的所有剩余内容,并添加额外的临床场景和基于性能的交互活动。我们将使用三种训练方法的附加研究设计来测试该计划在 RCT (N=180) 中的功效:文本 (n=60)、文本 + PCT OLT (PCT OLT;n=60) 与文本 + PCT OLT + 专家每周咨询(混合;n= 60)。结果变量将再次包括 PCT 知识以及使用 PCT 治疗 PDA 客户的自我效能。我们将扩大评估范围,纳入计算机生成的临床应用测试,测试其能力以及对 PCT 和课程完成情况的忠诚度。受试者将在培训前和培训后接受评估,然后在培训后 30 天和 60 天的随访中再次评估。
公共卫生相关性:虽然对于诊断为恐慌症 (PD) 的人确实存在基于经验的治疗,但该人群中只有相对较小的比例会接受此类治疗。恐慌控制治疗(又称掌握焦虑和恐慌;MAP)是治疗帕金森病的有效方法。该项目的目的是开发一种独特的全面、交互式的 MAP 在线培训,以帮助传播这种基于证据的治疗方法,从而改善 PD 患者的临床结果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David H. Barlow其他文献
Discriminating between generalized anxiety disorder and anxiety disorder not otherwise specified in a Hispanic population: Is it only a matter of worry?
区分广泛性焦虑症和西班牙裔人群中未特指的焦虑症:这只是担心的问题吗?
- DOI:
- 发表时间:
1997 - 期刊:
- 影响因子:7.4
- 作者:
L. Street;E. Salmán;Robin Garfinkle;Joao Silvestri;José L. Carrasco;D. Cárdenas;R. Zinbarg;David H. Barlow;M. Liebowitz - 通讯作者:
M. Liebowitz
The effects of attentional focus and partner responsiveness on sexual responding: Replication and extension
注意力集中和伴侣反应对性反应的影响:复制和延伸
- DOI:
10.1007/bf01550851 - 发表时间:
1985-08-01 - 期刊:
- 影响因子:3.8
- 作者:
D. Abrahamson;David H. Barlow;J. Gayle Beck;D. K. Sakheim;John P. Kelly - 通讯作者:
John P. Kelly
A Practitioner’s Guide
从业者指南
- DOI:
- 发表时间:
2006 - 期刊:
- 影响因子:0
- 作者:
Jeffrey E. Young;J. Klosko;M. Weishaar;David H. Barlow;Jeffrey E. Young;J. Klosko;M. Weishaar - 通讯作者:
M. Weishaar
Unified Protocol for Transdiagnostic Treatment of Emotional Disorders: Therapist Guide
情绪障碍跨诊断治疗的统一方案:治疗师指南
- DOI:
- 发表时间:
2010 - 期刊:
- 影响因子:0
- 作者:
David H. Barlow;T. Farchione;C. Fairholme;K. Ellard;Christina L. Boisseau;Laura B. Allen;Jill Ehrenreich - 通讯作者:
Jill Ehrenreich
David H. Barlow的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David H. Barlow', 18)}}的其他基金
Efficacy Evaluation of Transdiagnostic CBT for Comorbid Alcohol Use and Anxiety Disorder
跨诊断 CBT 对共病酒精使用和焦虑症的疗效评估
- 批准号:
9263535 - 财政年份:2017
- 资助金额:
$ 70.54万 - 项目类别:
Efficacy Evaluation of a Unified Transdiagnostic Treatment for Anxiety Disorders
焦虑症统一跨诊断治疗的疗效评估
- 批准号:
8391726 - 财政年份:2010
- 资助金额:
$ 70.54万 - 项目类别:
Efficacy Evaluation of a Unified Transdiagnostic Treatment for Anxiety Disorders
焦虑症统一跨诊断治疗的疗效评估
- 批准号:
8538551 - 财政年份:2010
- 资助金额:
$ 70.54万 - 项目类别:
Efficacy Evaluation of a Unified Transdiagnostic Treatment for Anxiety Disorders
焦虑症统一跨诊断治疗的疗效评估
- 批准号:
8589008 - 财政年份:2010
- 资助金额:
$ 70.54万 - 项目类别:
Efficacy Evaluation of a Unified Transdiagnostic Treatment for Anxiety Disorders
焦虑症统一跨诊断治疗的疗效评估
- 批准号:
8207886 - 财政年份:2010
- 资助金额:
$ 70.54万 - 项目类别:
Efficacy Evaluation of a Unified Transdiagnostic Treatment for Anxiety Disorders
焦虑症统一跨诊断治疗的疗效评估
- 批准号:
8040318 - 财政年份:2010
- 资助金额:
$ 70.54万 - 项目类别:
Interdisciplinary Study of Two Novel Anticonvulsants in Alcoholism
两种新型抗惊厥药治疗酒精中毒的跨学科研究
- 批准号:
8990076 - 财政年份:2009
- 资助金额:
$ 70.54万 - 项目类别:
Interdisciplinary Study of Two Novel Anticonvulsants in Alcoholism
两种新型抗惊厥药治疗酒精中毒的跨学科研究
- 批准号:
9353265 - 财政年份:2009
- 资助金额:
$ 70.54万 - 项目类别:
相似国自然基金
基于动态信息的深度学习辅助设计成人脊柱畸形手术方案的研究
- 批准号:82372499
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
单核细胞产生S100A8/A9放大中性粒细胞炎症反应调控成人Still病发病及病情演变的机制研究
- 批准号:82373465
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SERPINF1/SRSF6/B7-H3信号通路在成人B-ALL免疫逃逸中的作用及机制研究
- 批准号:82300208
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Social Vulnerability, Sleep, and Early Hypertension Risk in Younger Adults
年轻人的社会脆弱性、睡眠和早期高血压风险
- 批准号:
10643145 - 财政年份:2023
- 资助金额:
$ 70.54万 - 项目类别:
Implementing SafeCare Kenya to Reduce Noncommunicable Disease Burden: Building Community Health Workers' Capacity to Support Parents with Young Children
实施 SafeCare Kenya 以减少非传染性疾病负担:建设社区卫生工作者支持有幼儿的父母的能力
- 批准号:
10672785 - 财政年份:2023
- 资助金额:
$ 70.54万 - 项目类别:
A cloud-based digital health navigation program for colorectal cancer screening
基于云的结直肠癌筛查数字健康导航程序
- 批准号:
10697474 - 财政年份:2023
- 资助金额:
$ 70.54万 - 项目类别:
Center for Harmonizing and Improving Interventions to Prevent Suicide (CHIIPS)
协调和改进预防自杀干预措施中心 (CHIIPS)
- 批准号:
10662785 - 财政年份:2023
- 资助金额:
$ 70.54万 - 项目类别:
Sex, Physiological State, and Genetic Background Dependent Molecular Characterization of CircuitsGoverning Parental Behavior
控制父母行为的回路的性别、生理状态和遗传背景依赖性分子特征
- 批准号:
10661884 - 财政年份:2023
- 资助金额:
$ 70.54万 - 项目类别: